DIRS.INFO The most relevant business & tech news

☆ Three quarters of UK long COVID sufferers working less -survey
▼ + stars: | 2022-11-09 | by ( David Milliken | ) www.reuters.com time to read: +2 min

The survey of 1,002 people, conducted by market research company Censuswide in October for recruitment website Indeed, adds to signs that long COVID continues to be a factor behind widespread labour shortages in Britain. Some 98% of long COVID sufferers said the condition had limited their ability to work, 78% had needed to cut back or change their work and 19% had ceased work altogether. Long COVID, a collection of symptoms ranging from pain and heart palpitations to insomnia and brain fog, can last for many months after initial infection. Of those, 73% said long COVID was limiting their day-to-day activities, and 16% - 333,000 people - said their activities had been significantly limited. In the Indeed survey, 59% of people diagnosed with long COVID said they felt more tired, 42% felt physically weaker, 37% found it harder to concentrate and 19% were in pain when working.

Formerly a prodigious amateur, for eight years Brewerton had traveled the world competing at the summit of women’s professional golf. Regular top-10 finishes became fleeting, then non-existent, and as Brewerton’s ranking tumbled, so too did her income. Despite her struggles in the game, Brewerton never fell out of love with golf. Looking back, Brewerton believes she was often guilty of over-training, at the expense of working on the mental side of her game. Comfortably inside the top-20 ranked players on the LET, Brewerton is enjoying her best season in a decade, with three top-10 finishes highlighting a flurry of top-25 outings.

☆ U.S. government to test Pfizer's Paxlovid for long COVID
▼ + stars: | 2022-10-27 | by ( Julie Steenhuysen | ) www.reuters.com time to read: +2 min

According to details of the study, posted on Clinicaltrials.gov, the randomized, placebo-controlled trial will test Pfizer's treatment or a placebo in 1,700 volunteers aged 18 and older. The trial will investigate a leading theory of the cause of long COVID, which holds that fragments of the virus persist in the tissues of some individuals, causing prolonged symptoms. Patients in several case studies have reported improvements in their symptoms after taking Pfizer's antiviral treatment, and several physicians have called for the drug to be studied in a large, scientifically rigorous study in patients with long COVID. Estimates of long COVID prevalence range from 5 to 50% of people who have had a COVID-19 infection. It affects people who have had both mild and severe COVID-19, including children, and can be severe enough to keep people out of work.

☆ Addiction drug shows promise lifting long COVID brain fog, fatigue
▼ + stars: | 2022-10-18 | by ( Julie Steenhuysen | Nancy Lapid | ) www.reuters.com time to read: +6 min

Lauren Nichols, who has long COVID, takes a break and rests in a lounge bed in the office in her home in Andover, Massachusetts, U.S., August 3, 2022. Register now for FREE unlimited access to Reuters.com RegisterResearchers chasing long COVID cures are eager to learn whether the drug can offer similar benefits to millions suffering from pain, fatigue and brain fog months after a coronavirus infection. Younger, author of a scientific review of the drug as a novel anti-inflammatory, in September submitted a grant application to study LDN for long COVID. It worked so well that he ran a pilot study among 38 long COVID patients. He studied LDN in 18 long COVID patients, with 11 showing improvements, and said he believes larger, formal trials could determine whether LDN offers a true benefit.

☆ Long COVID at 12 months persists at 18 months, study shows
▼ + stars: | 2022-10-13 | by ( Nancy Lapid | ) www.reuters.com time to read: +3 min

REUTERS/Carlo AllegriOct 13 (Reuters) - Most patients with COVID-19 who have lingering symptoms at 12 months are likely to still have symptoms at 18 months, new data suggest. Among a subset of 197 survivors of symptomatic SARS-CoV-2 infections who completed surveys at 12 months and 18 months, most reported lingering symptoms at both time points, researchers reported in Nature Communications. Register now for FREE unlimited access to Reuters.com RegisterRates of no recovery at 12 months were 11% with 51% partial recovery and 39% complete recovery. At six months, 8% reported no recovery, 47% reported partial recovery, and 45% reported complete recovery. Those rates had barely changed at 12 months, with 8% reporting no recovery, 46% partial recovery and 46% complete recovery.

But "we know that one in three women are going to die of heart disease" every year. Heart attackA heart attack occurs when blood flow to the heart muscle is cut off or drastically reduced. Women with heart failure have a wider variety of symptom, such as sweating, unusual swelling, heart palpitations and feelings of heartburn. According to the review, 10% of people with heart disease experience depression, compared with 5% of those without heart problems. Heart valve diseaseHeart valve disease occurs when one or more of valves in the heart doesn't work properly.

Search resuls for: "palpitations"

6 mentions found